Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference [Yahoo! Finance]
Cabaletta Bio, Inc. (CABA)
Company Research
Source: Yahoo! Finance
I/II datasets across systemic sclerosis, lupus nephritis and myasthenia gravis in H1, with potential FDA alignment to start a scleroderma pivotal study later this year. No-preconditioning CAR-T strategy (avoiding fludarabine/cyclophosphamide) is being pursued after early pemphigus patients showed partial to robust responses at 1M cells/kg; a lupus no-preconditioning cohort has opened and higher-dose pemphigus data are expected later this year. Cellares automated manufacturing is central to Cabaletta's plan to lower cost-of-goods and scale production with minimal capital—management said a first product was successfully manufactured and cleared QC, with dosing expected imminently. Interested in Cabaletta Bio, Inc.? Here are five stocks we like better. Cabaletta Bio (NASDAQ:CABA) used a fireside chat at TD Cowen's 46th Annual Health Care Conference to highlight progress across its autoimmune cell therapy program, with executives emphasizing upcoming clinical readouts, a push towa
Show less
Read more
Impact Snapshot
Event Time:
CABA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CABA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CABA alerts
High impacting Cabaletta Bio, Inc. news events
Weekly update
A roundup of the hottest topics
CABA
News
- Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]Yahoo! Finance
- Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care ConferenceGlobeNewswire
- Here's Why Jacob Funds Established a Position in Cabaletta Bio (CABA) [Yahoo! Finance]Yahoo! Finance
- Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]Yahoo! Finance
- Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026GlobeNewswire
CABA
Earnings
- 11/10/25 - Beat
CABA
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- CABA's page on the SEC website